Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 52

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 52
---
 in a change of control. Our major shareholders do not have different voting rights than other
holders of our Ordinary Shares.

To our knowledge, other than
due to the expiration of unexercised warrants held by our shareholders or as otherwise disclosed elsewhere in, or incorporated by reference
into, this prospectus, there has been no significant change in the percentage ownership of our Ordinary Shares held by the principal shareholders
listed above in the last three years.

| 33 |

<div align='center'>DESCRIPTION OF SECURITIES WE ARE OFFERING</div>

We are offering Units, each
Unit consisting of one Depositary Share and one Series L Warrant to purchase one Depositary Share. We are also offering to each purchaser
whose purchase of Depositary Shares in this offering would otherwise result in the purchaser, together with its affiliates, beneficially
owning more than 4.99% (or, at the election of the purchaser, up to 9.99%) of our outstanding Ordinary Shares immediately following the
consummation of this offering, the opportunity to purchase, if the purchaser so chooses, Pre-Funded Units containing Pre-Funded Warrants
in lieu of the Depositary Shares that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% (or, at the
election of the purchaser, up to 9.99%) of our outstanding Depositary Shares. For each Pre-Funded Unit we sell (without regard to any
limitation on exercise set forth therein), the number of Units including a Depositary Share we are offering will be decreased on a one-for-one
basis. Because one Series L Warrant is being sold together in this offering with each Depositary Share or, in the alternative, each Pre-Funded
Warrant to purchase one Depositary Share, the number of Series L Warrants sold in this offering will not change as a result of a change
in the mix of the Depositary Shares and Pre-Funded Warrants sold.

The Units have no standalone
rights and will not be certificated or issued as standalone securities. The Depositary Shares or Pre-Funded Warrants and Series L Warrants
comprising the Units are immediately separable and will be issued separately in this offering.

American Depositary Shares

Please see the sections titled
“Description of American Depositary Shares” and “Description of Share Capital” in this prospectus
for a description of the material terms of our American Depositary Shares and the underlying Ordinary Shares and our Articles of Association.

Pre